Results 261 to 270 of about 20,192,591 (347)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Employment quality and mortality in Canada. [PDF]

open access: yesJ Epidemiol Community Health
Shahidi FV   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy